Nowak, Christoph
Carlsson, Axel C.
Östgren, Carl Johan
Nyström, Fredrik H.
Alam, Moudud
Feldreich, Tobias
Sundström, Johan
Carrero, Juan-Jesus
Leppert, Jerzy
Hedberg, Pär
Henriksen, Egil
Cordeiro, Antonio C.
Giedraitis, Vilmantas
Lind, Lars
Ingelsson, Erik
Fall, Tove
Ärnlöv, Johan
Funding for this research was provided by:
Vetenskapsrådet (2015-03477)
Sparbanksstiftelsen Nya (932)
Hjärt-Lungfonden (20150429)
European Union Horizon 2020 (634869)
Region Västmanland
Sveriges Läkarförbund
Dalarna University
Landstinget Dalarna
Article History
Received: 19 February 2018
Accepted: 18 April 2018
First Online: 24 May 2018
Duality of interest
: EI is a scientific advisor for Olink Proteomics for projects unrelated to the present study. The company had no influence over the design, analysis or interpretation of data in the present study, and did not provide any funding for the study. JÄ has received lecturing fees from AstraZeneca unrelated to the present project. The authors report that there are no other duality of interests associated with their contribution to this manuscript.